IP Library Granted Patent US 9,051,410
Granted Patent B2
US 9,051,410 · App. 13/384,295 · Granted Jun 9, 2015

Polyurea-based fabric glue

Inventors: Heike Heckroth (Odenthal, DE); Hartmut Nefzger (Pulheim, DE); Christoph Eggert (Köln, DE)
Assignee: Medical Adhesive Revolution GmbH
C08G18/10A61L24/046C08G18/18C09J175/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,051,410
App. No.
13/384,295
Granted
Jun 9, 2015
Kind
B2
Abstract

The present invention relates to a polyurea system, the use of such a polyurea system for sealing, linking, gluing, or covering of cellular tissue, and a dosing system having two chambers for a polyurea system such as this. The polyurea system comprises as components: A) an isocyanate-functioning prepolymer, which can be derived by reacting aliphatic isocyanates with polyoles, and B) an amino-functioning ester of aspartic acid. According to the invention, water and/or tertiary amine is added to the system, in order to increase the reacting speed of the prepolymer with the amino-functioning ester of aspartic acid while decreasing the setting time at the same time.

Claims (26)

1. A polyurea system comprising

A) isocyanate-functional prepolymers obtained by reacting

aliphatic isocyanates A1) with

polyols A2) which have a number-average molecular weight of ≧400 g/mol and an average OH functionality of 2 to 6,

B) amino-functional aspartic esters of formula (I)

 wherein

X is an organic radical containing no Zerewitinoff-active hydrogen,

R 1 and R 2

are identical or different organic radicals containing no Zerewitinoff-active hydrogen, and

n is an integer of at least 2,

and/or

optionally C) organic fillers and

optionally D) reaction products of the isocyanate-functional prepolymers of A) with aspartic esters B) and/or organic fillers C),

wherein said system comprises water and tertiary amine as E), wherein the tertiary amine is selected from the group consisting of N,N-dimethyl-2-(4-methylpiperazin-1-yl)ethanamine, 2-[{2-(dimethylamino)ethyl](methyl)amino}ethanol, and 3,3′,3″-(1,3,5-triazinane-1,3,5-triyl)tris(N,N-dimethylpropan-1-amine).

2. The polyurea system of claim 1 , wherein said polyurea system contains 0.2% to 2.0% by weight of water and/or 0.1% to 1.0% by weight of tertiary amine.

3. The polyurea system of claim 1 , wherein X is an optionally branched or linear organic radical having 1 to 20 carbon atoms which optionally contains heteroatoms.

4. The polyurea system of claim 1 , wherein the polyols A2) comprise polyester polyols and/or polyester-polyether polyols and/or polyether polyols.

5. The polyurea system of claim 4 , wherein the polyols used for preparing component A) have a number-average molecular weight of 4000 to 8500 g/mol.

6. The polyurea system of claim 1 , wherein the organic fillers of component C) are hydroxyl-functional compounds.

7. The polyurea system of claim 6 , wherein the fillers of component C) have an average OH functionality of 1.5 to 3.

8. The polyurea system of claim 6 , wherein the fillers of component C) have repeating ethylene oxide units.

9. The polyurea system of claim 1 for sealing, connecting, bonding or covering cellular tissue, more particularly for staunching the egress of blood or tissue fluids or for sealing leaks in cellular tissue.

10. The polyurea system of claim 9 for use for sealing, connecting, bonding or covering human or animal cellular tissue.

11. A composition for sealing, connecting, bonding, or covering cellular tissue comprising the polyurea system of claim 1 .

12. The composition of claim 11 , wherein said composition is used for sealing, connecting, bonding or covering human or animal cellular tissue.

13. A metering system having two chambers for a polyurea system as claimed in claim 1 , wherein one chamber contains component A) and the other chamber contains components B) and E) or B), D)+E), and, optionally, components C) and D) of the polyurea system.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT APPL. NO. 13/369,744 PREVIOUSLY RECORDED AT REEL: 038810 FRAME: 0860. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Jul 21, 2016
From: MEDICAL ADHESIVE REVOLUTION GMBH
To: ADHESYS MEDICAL GMBH
Reel/Frame 039427/0230 →
CHANGE OF NAME Recorded Jul 21, 2016
From: MEDICAL ADHESIVE REVOLUTION GMBH
To: ADHESYS MEDICAL GMBH
Reel/Frame 039463/0394 →
CHANGE OF NAME Recorded May 25, 2016
From: MEDICAL ADHESIVE REVOLUTION GMBH
To: ADHESYS MEDICAL GMBH
Reel/Frame 038810/0860 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S ADDRESS PREVIOUSLY RECORDED AT REEL: 033489 FRAME: 0635. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 30, 2014
From: BAYER MATERIALSCIENCE AG
To: MEDICAL ADHESIVE REVOLUTION GMBH
Reel/Frame 033907/0247 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2014
From: BAYER MATERIALSCIENCE AG
To: MEDICAL ADHESIVE REVOLUTION GMBH
Reel/Frame 033489/0635 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2012
From: HECKROTH, HEIKE; NEFZGER, HARTMUT; EGGERT, CHRISTOPH
To: BAYER MATERIALSCIENCE AG
Reel/Frame 027924/0819 →
Priority Claims (1)
EP 09009248 · Jul 16, 2009 · regional
Continuity (1)
Related Publication 20120178847A1 · Jul 12, 2012